Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0J6RV
|
|||
| Former ID |
DIB013697
|
|||
| Drug Name |
BAY1161909
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 1 | [1] | |
| Company |
Bayer healthcare pharmaceuticals
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C29H26FN5O4S
|
|||
| Canonical SMILES |
CC(C1=CC=C(C=C1)F)C(=O)NC2=CC=C(C=C2)C3=CN4C(=NC(=N4)NC5=C(C=C(C=C5)S(=O)(=O)C)OC)C=C3
|
|||
| InChI |
1S/C29H26FN5O4S/c1-18(19-4-9-22(30)10-5-19)28(36)31-23-11-6-20(7-12-23)21-8-15-27-33-29(34-35(27)17-21)32-25-14-13-24(40(3,37)38)16-26(25)39-2/h4-18H,1-3H3,(H,31,36)(H,32,34)/t18-/m1/s1
|
|||
| InChIKey |
NRJKIOCCERLIDG-GOSISDBHSA-N
|
|||
| CAS Number |
CAS 1443763-60-7
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Dual specificity protein kinase TTK (MPS1) | Target Info | Inhibitor | [2] |
| KEGG Pathway | Cell cycle | |||
| NetPath Pathway | IL2 Signaling Pathway | |||
| WikiPathways | Retinoblastoma (RB) in Cancer | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800040625) | |||
| REF 2 | National Cancer Institute Drug Dictionary (drug id 761238). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.